Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2026-06-02 16:05:28 ET · period of report 2026-05-31 · accession 0001468316-26-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-02 16:05 | 2026-05-31 | FENC | Raykov Rosty | Dir | A - Grant | $0.00 | +2,778 | 124.2K | +2% | $0 |
| DT | 2026-06-02 16:05 | 2026-06-01 | FENC | Raykov Rosty | Dir | M - OptEx | $2.45 | +15.6K | 139.8K | +13% | +$38.2K |
| DT | 2026-06-02 16:05 | 2026-06-01 | FENC | Raykov Rosty | Dir | S - Sale+OE | $9.62 | -9,747 | 130.1K | -7% | -$93.8K |
| DT | 2026-06-02 16:05 | 2026-06-01 | FENC | Raykov Rosty | Dir | M - OptEx | $2.45 | -15.6K | 1.56M | -1.0% | -$38.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2026-05-31 | A | A | 2,778 | $0.00 | 124,229 | D | — | — | (F1) Represents shares released from restriction from shares awarded 5/16/2024. |
| 2 | Common | Common shares | 2026-06-01 | M | A | 15,597 | $2.45 | 139,826 | D | — | — | (F2) Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on September 19, 2025. |
| 3 | Common | Common shares | 2026-06-01 | S | D | 9,747 | $9.62 | 130,079 | D | — | — | (F3) Shares sold to satisfy tax obligation on option exercise pursuant to a 10b5-1 plan adopted on September 19, 2025. |
| 4 | Derivative | Stock Options | 2026-06-01 | M | D | 15,597 | $2.45 | 1,556,195 | D | $2.45 · 2016-07-05 to 2026-07-05 | 15,597 options | (F4) Represents options exercised pursuant to a 10b5-1 plan adopted on September 19, 2025. |